Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 31767 | 118 | 19.1 | 56% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1919 | 5291 | RESTRICTION ENDONUCLEASE//RESTRICTION MODIFICATION//RESTRICTION MODIFICATION SYSTEM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | EXPT BIOTECHNOL PLANT | Address | 3 | 100% | 3% | 3 |
| 2 | HUMAN CONSENSUS INTERFERON ALPHA | Author keyword | 2 | 67% | 2% | 2 |
| 3 | A21 DESAMIDOINSULIN | Author keyword | 1 | 100% | 2% | 2 |
| 4 | RECOMBINANT PROTEINS ANALYSIS | Author keyword | 1 | 100% | 2% | 2 |
| 5 | SHEMYAKIN OVCHINNIKOV | Address | 1 | 50% | 2% | 2 |
| 6 | CITRACONYLATION | Author keyword | 1 | 33% | 2% | 2 |
| 7 | COMMERCIAL INJECTIONS | Author keyword | 1 | 50% | 1% | 1 |
| 8 | HUMAN INSULIN LIKE GROWTH FACTOR I | Author keyword | 1 | 50% | 1% | 1 |
| 9 | IN 105 | Author keyword | 1 | 50% | 1% | 1 |
| 10 | ISULIN | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOSYNTHETIC HUMAN INSULIN | 2 | 22% | 5% | 6 |
| 2 | RECOMBINANT HUMAN INSULIN | 1 | 30% | 3% | 3 |
| 3 | INSULIN PRECURSORS | 0 | 33% | 1% | 1 |
| 4 | MUTANOLYSIN | 0 | 13% | 1% | 1 |
| 5 | MINI PROINSULIN | 0 | 11% | 1% | 1 |
| 6 | ALPHA 8 | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| SHORT HOMOPEPTIDE LEADER SEQUENCES ENHANCED PRODUCTION OF HUMAN PROINSULIN IN ESCHERICHIA-COLI | 1987 | 2 | 6 | 50% |
| Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy | 2013 | 1 | 33 | 3% |
| SYNTHETIC DNA FRAGMENTS AS USEFUL TOOLS IN GENETIC AND PROTEIN ENGINEERING | 1986 | 3 | 80 | 16% |
| RECOMBINANT DNA | 1985 | 0 | 32 | 6% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXPT BIOTECHNOL PLANT | 3 | 100% | 2.5% | 3 |
| 2 | SHEMYAKIN OVCHINNIKOV | 1 | 50% | 1.7% | 2 |
| 3 | CKDBIO | 0 | 33% | 0.8% | 1 |
| 4 | THER EUT PROTECT PROT | 0 | 13% | 0.8% | 1 |
| 5 | HUMORAL IMMUN PROF RICARDO A MARGNI IDEHU | 0 | 10% | 0.8% | 1 |
| 6 | BIOTECH CMC | 0 | 100% | 0.8% | 1 |
| 7 | CITY SCI BIOTECHNOL PLICAT | 0 | 100% | 0.8% | 1 |
| 8 | EDULING PLANNING PLICAT | 0 | 100% | 0.8% | 1 |
| 9 | PROTEIN GENET ENGN BIOTECHNOL | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000183739 | MONOMERIC INSULIN//INSULIN MUTANT//SINGLE CHAIN INSULIN |
| 2 | 0.0000166250 | SD SEQUENCE//RIBOSOMAL PROTEIN S1//SHINE DALGARNO SEQUENCE |
| 3 | 0.0000149494 | MEGAPRIMER//OVERLAP EXTENSION//MULTIPLE SITE DIRECTED MUTAGENESIS |
| 4 | 0.0000136176 | ENTEROPEPTIDASE//DUODENASE//ENTEROKINASE |
| 5 | 0.0000135289 | PROTEIN REFOLDING//INCLUSION BODIES//REFOLDING |
| 6 | 0.0000131291 | H PHOSPHONATES//OLIGONUCLEOTIDE SYNTHESIS//UNIVERSAL SOLID SUPPORT |
| 7 | 0.0000113226 | PHOSPHOROTHIOLATE//P 32ORTHOPHOSPHORIC ACID//SYNTHESIS OF P 32 LABELED NUCLEOTIDES |
| 8 | 0.0000106689 | STOICHIOMETRIC DISPLACEMENT//MODERN SEPARAT SCI//PEPTIDE RETENTION PREDICTION |
| 9 | 0.0000096684 | CNRS BIOCHIM THEOR//AUTOSTEREOGRAM//TRANSFORMATION OF DATA |
| 10 | 0.0000091034 | SPI SELECTION//CO PRECIPITANT//INSERT SIZE |